Locke Lord LLP advised Biohaven Pharmaceutical Holding Company on the deal. Biohaven Pharmaceutical Holding Company announced a $60 million Series A Preferred equity financing of BioShin…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now